These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11430476

  • 1. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
    Tokioka-Akagi T, Fujimori A, Shibasaki M, Inagaki O, Yanagisawa I.
    Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
    [Abstract] [Full Text] [Related]

  • 2. Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
    Tokioka T, Shibasaki M, Fujimori A, Matsuda-Satoh Y, Uchida W, Inagaki O, Yanagisawa I.
    Biol Pharm Bull; 2000 Feb; 23(2):174-81. PubMed ID: 10706380
    [Abstract] [Full Text] [Related]

  • 3. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M, Yuan B, Harmsen E, Leenen FH.
    Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
    [Abstract] [Full Text] [Related]

  • 4. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R, Young SD, Strosberg AM.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [Abstract] [Full Text] [Related]

  • 5. Effects of angiotensin II type 1 receptor antagonist, YM358, on cardiac hypertrophy and dysfunction after myocardial infarction in rats.
    Oka-Akagi T, Fujimori A, Shibasaki M, Matsuda-Satoh Y, Inagaki O, Yanagisawa I.
    Biol Pharm Bull; 2002 Jul; 25(7):857-60. PubMed ID: 12132657
    [Abstract] [Full Text] [Related]

  • 6. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M, Yuan B, Leenen FH.
    Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035
    [Abstract] [Full Text] [Related]

  • 7. The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.
    Ruzicka M, Keeley FW, Leenen FH.
    Circulation; 1994 Oct; 90(4):1989-96. PubMed ID: 7923689
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M, Fujimori A, Takanashi M, Kusayama T, Tokioka T, Satoh Y, Okazaki T, Uchida W, Inagaki O, Yanagisawa I.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):167-73. PubMed ID: 9369370
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
    Kanagawa R, Wada T, Sanada T, Ojima M, Inada Y.
    Jpn J Pharmacol; 1997 Mar 24; 73(3):185-90. PubMed ID: 9127812
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF, de Azevedo Carvalho AC, Pimentel EB, Mill JG, Nascimento JH.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar 24; 390(3):225-234. PubMed ID: 27915452
    [Abstract] [Full Text] [Related]

  • 16. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E, Hosoya K, Susic D, Frohlich ED.
    Hypertension; 1997 Jan 24; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy.
    Ruzicka M, Leenen FH.
    Circulation; 1995 Jan 01; 91(1):16-9. PubMed ID: 7805197
    [Abstract] [Full Text] [Related]

  • 20. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
    Taylor K, Patten RD, Smith JJ, Aronovitz MJ, Wight J, Salomon RN, Konstam MA.
    J Cardiovasc Pharmacol; 1998 May 01; 31(5):654-60. PubMed ID: 9593063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.